Klaus Frueh
President bij Tomegavax, Inc.
Profiel
Klaus Frueh is the founder of Vir Biotechnology, Inc. which was founded in 2016.
He held the title of Director from 2016 to 2019.
Currently, Dr. Frueh is the President & Secretary at Tomegavax, Inc.
Actieve functies van Klaus Frueh
| Bedrijven | Functie | Begin |
|---|---|---|
Tomegavax, Inc.
 Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | President | - |
Eerdere bekende functies van Klaus Frueh
| Bedrijven | Functie | Einde |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Oprichter | 16-10-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Tomegavax, Inc.
Tomegavax, Inc. Miscellaneous Commercial ServicesCommercial Services Tomegavax, Inc. provides health, science and drug services. It develops cures for AIDS, malaria, tuberculosis, herpes, papillomavirus and hepatitis-diseases where there’s no natural immunity in humans and traditional vaccine mechanisms don’t work. The company was founded in 2011 and is headquartered in Beaverton, OR. | Commercial Services |
